Charles Kummeth
2021
In 2021, Charles Kummeth earned a total compensation of $15.9M as President and CEO at Bio-Techne, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,537,214 |
|---|---|
| Option Awards | $6,599,940 |
| Salary | $1,116,000 |
| Stock Awards | $4,599,864 |
| Other | $36,879 |
| Total | $15,889,896 |
Kummeth received $6.6M in option awards, accounting for 42% of the total pay in 2021.
Kummeth also received $3.5M in non-equity incentive plan, $1.1M in salary, $4.6M in stock awards and $36.9K in other compensation.
Rankings
In 2021, Charles Kummeth's compensation ranked 484th out of 12,415 executives tracked by ExecPay. In other words, Kummeth earned more than 96.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 484 out of 12,415 | 96th |
Division Manufacturing | 156 out of 5,505 | 97th |
Major group Chemicals And Allied Products | 47 out of 2,375 | 98th |
Industry group Drugs | 42 out of 2,096 | 98th |
Industry Biological Products, Except Diagnostic Substances | 17 out of 449 | 96th |
Source: SEC filing on September 14, 2022.
Kummeth's colleagues
We found four more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2021.